NxStage manufactures and commercializes home hemodialysis devices and products for the treatment of kidney failure and renal diseases.
Business Model:
Revenue: $400M
Employees: 501-1,000
NxStage was acquired by
Fresenius Medical Care.
The acquisition happend on 2017-08-07.
Details of the transaction were not public
Address: 350 Merrimack Street
City: Lawrence
State: MA
Zip: 01843
Country: US
NxStage manufactures and commercializes home hemodialysis devices and products for the treatment of kidney failure and renal diseases.
Contact Phone:
+18666978243
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
11/4/2005
Ticker Symbol:
NXTM
Amount Raised:
$55M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2004 | Equity | $20M |
Wasatch Advisors Credit Suisse First Boston Marubeni Group Atlas Venture Adams Street Partners Lightspeed Venture Partners |
10/2005 | IPO | $55M | 5/2008 | Post-IPO Equity | 1 | $5.6M |
Deepfield Deepfield Deepfield Deepfield |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|